Jessica Mitacek, Associate Editor & Contributing Author at MarketBeat

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Experience

Jessica Mitacek has been an associate editor & contributing writer for MarketBeat since 2023.

Areas of Expertise

Market analysis and research, technology, retail

Education

Bachelor of Arts in English & Spanish, University of Vermont

Past Experience

Hedge Funds, Private Equity Funds, long/short equities, distressed debt, investor relations

Learn About MarketBeat's Editorial Guidelines and Standards Policy

Latest Articles by Jessica Mitacek

March 14, 2024 8:51 AM ET

Mastering Stocks in the Dow: Insights into the DJIA

Jessica Mitacek

What is the Dow Jones Industrial Average (DJIA)? The Dow Jones Industrial Average includes 30 companies, once all industrial companies. Learn more.

NYSE:AXPNASDAQ:AMGNNASDAQ:AAPL

March 7, 2024 10:00 AM ET

Here's How to Dip into Chinese Stocks if You Live in the U.S.

Jessica Mitacek

Wondering how to invest in Chinese stocks? China has the globe’s largest population and second-largest economy when measured by GDP.

NYSE:BABANASDAQ:BIDUOTCMKTS:TCEHY

February 29, 2024 10:57 AM ET

How to Get in on the Blockchain Boom with Blockchain Stocks

Jessica Mitacek

Blockchain stocks offer a plethora of investment opportunities. Learn how to invest in blockchain stocks and take advantage of the blockchain boom.

NASDAQ:RIOTNASDAQ:OSTKNASDAQ:COIN

February 23, 2024 9:50 AM ET

How to invest in apparel stocks

Jessica Mitacek

If you’re interested in investing in clothing, consider investing in apparel stocks. Learn more about how to invest in apparel stocks with MarketBeat.

NYSE:ANFOTCMKTS:ADDYYNYSE:AEO

February 13, 2024 10:51 AM ET

What are earnings reports?

Jessica Mitacek

Earnings reports are part of the legal requirements that publicly held companies follow when disclosing their company performance, issued quarterly.

NYSE:ANNNASDAQ:AAPLNYSE:LEA

January 31, 2024 9:27 AM ET

10 best sugar stocks to buy now

Jessica Mitacek

No individual sugar-producing companies trade on major U.S. stock exchanges, so should you invest? Learn more about the best sugar stocks to buy on MarketBeat.

NASDAQ:KRFT)CNSX:AGRONYSE:AGRO

January 4, 2024 12:06 PM ET

Is American Airlines a good stock to buy?

Jessica Mitacek

Is American Airlines a good stock to buy? Here’s an analysis of the nation’s largest airline carrier to help you decide if American Airlines is a buy or sell.

NASDAQ:AALNASDAQ:UALNYSE:DAL

December 29, 2023 11:50 AM ET

Do bank stocks go up when interest rates rise?

Jessica Mitacek

Rising interest rates usually negatively affect the stock market, but do bank stocks go up when interest rates rise? Learn more with MarketBeat.

NYSE:BACNASDAQ:MOVE

December 14, 2023 11:52 AM ET

3 home improvement stocks to renovate your portfolio

Jessica Mitacek

Are home improvement stocks the way forward? Learn more about whether or not home improvement stocks make sense for your portfolio with MarketBeat.

NYSE:LOWNYSE:HDNYSE:SHW

December 14, 2023 10:53 AM ET

What is consumer discretionary?

Jessica Mitacek

What is consumer discretionary? In a strong economy, consumers spend more on consumer discretionary products. Learn more with MarketBeat.

NASDAQ:EXANASDAQ:AMZNOTCMKTS:CMG.B

December 14, 2023 10:03 AM ET

Comparing IRA vs. CD vs. money market accounts

Jessica Mitacek

What are the differences between an IRA, CD and money market account? Learn more about a IRA vs CD vs money market account with MarketBeat.

November 6, 2023 9:15 AM ET

There’s nothing artificial about NVIDIA’s relationship with AI

Jessica Mitacek

NVIDIA shares have skyrocketed over 220% so far this year, mainly thanks to increased interest in artificial intelligence, causing demand to for chips soar.

NASDAQ:NVDA

July 28, 2023 8:30 AM ET

7 Best Industrial REITs to Buy Now

Jessica Mitacek

Industrial REITs focus on storage, logistics or other types of industrial applications. Learn more about investing in industrial REITs and the best to buy.

NYSE:CTSE:DIR.UNTSE:DIR

May 30, 2023 11:00 PM ET

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccines

NYSEARCA:SBIONASDAQ:AMGNNASDAQ:BMRN

May 10, 2023 9:38 AM ET

How to Invest in E-Commerce: A Guide

Jessica Mitacek

Investing in e-commerce involves exploring opportunities in online retail marketplaces and technologies to capitalize on the sector's continued growth.

NASDAQ:EXANASDAQ:AMZNNASDAQ:CDNS

Latest Articles Reviewed by Jessica Mitacek

November 19, 2024 6:15 AM ET

3 High Flying Stocks That Could Stock Split in 2025

Jea Yu

Why Netflix, ASML, and ServiceNow are top candidates for stock splits in 2025. Strong growth, high valuations, and market strength make them ones to watch.

NASDAQ:NVDANYSE:CMGNASDAQ:AVGO

November 19, 2024 6:00 AM ET

Top IoT Stocks: Why Samsara and Digi Are Thriving in 2025

Jea Yu

Discover why Samsara (IOT) and Digi International (DGII) are top IoT stocks for 2025, with strong growth, innovative solutions, and long-term market potential.

NYSE:IOTNASDAQ:DGIINYSE:HD

November 19, 2024 6:00 AM ET

Retail Sector Comeback Plays: SPDR S&P Retail ETF, FND, and SHAK

Gabriel Osorio-Mazilli

Retail growth opportunities with XRT, Floor & Decor, and Shake Shack with strong margins, rising consumer spending, and 2024 momentum drive these investments.

NYSEARCA:XRTNYSE:SHAKNYSE:FND

November 19, 2024 5:45 AM ET

4 Reasons to Grab Shares of Grab Holdings Before 2024 Ends

Jea Yu

Grab Holdings posted its first net profit, raised 2024 guidance, and broke out of a bullish pattern. Here's why you should buy GRAB stock before year-end.

NASDAQ:GRABNYSE:UBER

November 19, 2024 5:30 AM ET

Instacart: Is it Time to Back Up the Cart on the Stock?

Jea Yu

Maplebear/Instacart beats Q3 earnings estimates but stock drops on conservative Q4 guidance. Discover why this could be a buying opportunity.

NASDAQ:CARTNASDAQ:DASHNYSE:UBER

November 19, 2024 5:00 AM ET

3 Under-the-Radar Oil Stocks to Keep Your Eye On

Nathan Reiff

Some energy stocks could benefit from a second Trump administration; keep an eye on these under-the-radar firms poised to rise with the broader industry.

NYSE:XOMNYSE:COPNYSE:SU

November 19, 2024 5:00 AM ET

Insiders Selling Into 3 Rallies: Investors Should Do the Opposite

Thomas Hughes

Insiders are selling into these three rallies, but investors shouldn't. The stocks rally for a reason, and insiders simply take advantage of high prices.

NASDAQ:NFLXNASDAQ:FASTNASDAQ:ISRG

November 18, 2024 6:57 AM ET

3 Ultra-High Dividend Yield Stocks for the New Year

Nathan Reiff

REITs and BDCs with high yields include AGNC, Rithm, and Prospect; these companies may appeal to investors looking to bulk up dividend payments.

NASDAQ:PSECNASDAQ:AGNCPNYSE:RITM

November 18, 2024 6:47 AM ET

Is Boeing Stock a Buy? 5 Pros and 1 Big Risk to Watch in 2024

Jea Yu

Discover 5 reasons why Boeing stock could rebound in 2024, from backlog to contracts, and 1 major risk to consider before investing.

NYSE:BANASDAQ:UALNASDAQ:AAL

November 18, 2024 6:17 AM ET

Why Buffett Dumped Apple and Bet Big on Domino’s Stock Instead

Gabriel Osorio-Mazilli

Here's why Warren Buffett sold Apple stock and invested in Domino's, signaling his outlook on inflation and the broader economy.

NYSE:DPZNASDAQ:ULTANYSE:COF

November 18, 2024 6:05 AM ET

Post-Election Rally Stalls, But These 3 Stocks Can Keep Going

Gabriel Osorio-Mazilli

Here's why Caterpillar, Exxon Mobil, and Adobe are post-election stock winners, leveraging a weaker dollar, energy growth, and high-margin tech trends in 2024.

NASDAQ:ADBENYSE:XOMNYSE:CAT

November 18, 2024 6:00 AM ET

General Mills Bets $1.45B on Pet Food: Growth or Risk?

Jeffrey Neal Johnson

General Mills' strategic pet food acquisition and strong Q1 earnings signal robust growth potential for investors.

NYSE:GIS

November 17, 2024 6:00 AM ET

MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?

Jeffrey Neal Johnson

MercadoLibre's growth strategy and dominant market position in Latin America make it a compelling investment opportunity despite recent earnings volatility.

NASDAQ:MELI

November 15, 2024 2:36 PM ET

How Whitestone REIT Is Transforming Sun Belt Retail Growth

Jeffrey Neal Johnson

Whitestone REIT's community-focused strategy in thriving markets drives impressive financial results and positions the company for continued growth.

NYSE:WSR

November 15, 2024 5:47 AM ET

Freshworks Stock Soars 50% – Is This the Perfect Entry Point?

Sam Quirke

Freshworks' recovery rally is sparking excitement among investors and making the stock one to watch closely as we head into the final few weeks of the year.

NASDAQ:FRSH

November 15, 2024 5:36 AM ET

3 High-Yields Unfazed by the Election: Altria, Truist, Verizon

Ryan Hasson

TFC, MO, and VZ offer high dividend yields, providing stability for income-focused investors amid extreme market moves, market volatility, and uncertainty.

NYSE:TFCNYSE:VZNYSE:MO

November 15, 2024 5:33 AM ET

Q3 Earnings Indicate On Holdings May Outperform Lululemon in 2024

Gabriel Osorio-Mazilli

Investors may be divided as to whether On Stock or Lululemon is the better pick in the retail sector; financial and price momentum have the answer.

NYSE:ONONNYSE:NKENASDAQ:LULU

November 14, 2024 8:50 AM ET

3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick

Leo Miller

GARP stocks Aptiv, Allstate, and Barrick blend growth potential and value and offer investors strong earnings outlooks and attractive PEG ratios.

NYSE:APTVNYSE:GOLDNYSE:ALL

November 14, 2024 5:15 AM ET

Can United States Cellular Ride Higher on Its Spectrum Strategy?

Leo Miller

US Cellular isn't one of the best known telecom stock, but its shares are up big due to its spectrum selling strategy. Can the stock continue to grow?

NASDAQ:TMUSNYSE:TNYSE:VZ

November 14, 2024 5:05 AM ET

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

Leo Miller

Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks.

NASDAQ:ACHCNASDAQ:NGNENASDAQ:TSHA

November 13, 2024 1:45 PM ET

What Is Volatility?

Sarah Horvath

Learn about different types of volatility, what drives it, and how it affects investment risk and returns to make informed financial decisions.

November 5, 2024 6:00 AM ET

Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving

Jea Yu

Health insurers face rising costs in Medicare Advantage. Centene and Molina stay profitable by focusing on Medicaid despite high Medical Benefits Ratios.

NYSE:CNCNYSE:CVSNYSE:MOH

November 5, 2024 5:30 AM ET

Options Traders Bet Big on These 3 Tech Stocks

Gabriel Osorio-Mazilli

New call option trades are being made around GOOG, HOOD, PYPL and investors need to reverse engineer these trades for profit.

NASDAQ:PYPLNASDAQ:GOOGNASDAQ:HOOD

November 5, 2024 5:00 AM ET

Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings

Chris Markoch

After strong earnings reports, Merck may be a better choice than Bristol-Meyers in the short term - but both may present a challenge for buy-and-hold investors.

NYSE:MRKNYSE:BMYNYSE:ABBV

Reports by Jessica Mitacek

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jessica Mitacek, Associate Editor & Contributing Author at MarketBeat

Jessica Mitacek

Associate Editor & Contributing Author

Experience

Areas of Expertise

Education

Past Experience

Latest Articles by Jessica Mitacek

Mastering Stocks in the Dow: Insights into the DJIA

Here's How to Dip into Chinese Stocks if You Live in the U.S.

How to Get in on the Blockchain Boom with Blockchain Stocks

How to invest in apparel stocks

What are earnings reports?

10 best sugar stocks to buy now

Is American Airlines a good stock to buy?

Do bank stocks go up when interest rates rise?

3 home improvement stocks to renovate your portfolio

What is consumer discretionary?

Comparing IRA vs. CD vs. money market accounts

There’s nothing artificial about NVIDIA’s relationship with AI

7 Best Industrial REITs to Buy Now

Top Biotech Stocks: Exploring Innovation Opportunities

How to Invest in E-Commerce: A Guide

Latest Articles Reviewed by Jessica Mitacek

3 High Flying Stocks That Could Stock Split in 2025

Top IoT Stocks: Why Samsara and Digi Are Thriving in 2025

Retail Sector Comeback Plays: SPDR S&P Retail ETF, FND, and SHAK

4 Reasons to Grab Shares of Grab Holdings Before 2024 Ends

Instacart: Is it Time to Back Up the Cart on the Stock?

3 Under-the-Radar Oil Stocks to Keep Your Eye On

Insiders Selling Into 3 Rallies: Investors Should Do the Opposite

3 Ultra-High Dividend Yield Stocks for the New Year

Is Boeing Stock a Buy? 5 Pros and 1 Big Risk to Watch in 2024

Why Buffett Dumped Apple and Bet Big on Domino’s Stock Instead

Post-Election Rally Stalls, But These 3 Stocks Can Keep Going

General Mills Bets $1.45B on Pet Food: Growth or Risk?

MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?

How Whitestone REIT Is Transforming Sun Belt Retail Growth

Freshworks Stock Soars 50% – Is This the Perfect Entry Point?

3 High-Yields Unfazed by the Election: Altria, Truist, Verizon

Q3 Earnings Indicate On Holdings May Outperform Lululemon in 2024

3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick

Can United States Cellular Ride Higher on Its Spectrum Strategy?

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

What Is Volatility?

Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving

Options Traders Bet Big on These 3 Tech Stocks

Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings

Reports by Jessica Mitacek

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools